News

Clinical Trials Arena52m
Regeneron and Sanofi’s dupilumab shows promise in AD trial
Regeneron and Sanofi have announced promising outcomes from the open-label Phase IV DISCOVER trial of Dupixent (dupilumab).
Clinical Trials Arena23h
Sobi and Apellis report new data from Phase III trial for C3G and IC-MPGN
Sobi and Apellis Pharmaceuticals have reported new results from the open-label period of the randomised Phase III VALIANT ...
Clinical Trials Arena22h
AI should unlock clinical trial data, say experts
Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...